SKYE

COM:SKYEBIOSCIENCE

Skye Bioscience

  • Stock

2.03

−6.88%

−1.98

USD last updated 25/07 01:50:18

Last Close

4.01

24/07 20:50

Market Cap

62.90M

Beta: -

Volume Today

275.73K

Avg: -

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical ...Show More